The office in Beijing's Chao Yang District will provide late-phase clinical trial services, including site management , biostatistics, data management, medical writing and regulatory affairs support.
General manager Vincent Yen said the office “will leverage QPS’ quality and training systems to offer customized, high-quality drug development solutions best suited for local Chinese biopharma, as well as global biopharma’s local affiliates.”
QPS has been building is presence in Asia since even before it acquired a majority stake in Qualitix Clinical Research in March last year. The process began in January 2011 when it invested in Indian bioanalytical services firm Bioserve Clinical Research.
The following month QPS bought the Taiwan Center of Toxicology’s preclinical services unit.